These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 22123068)

  • 1. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
    Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
    Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of a novel non-peptide αvβ3 integrin antagonist for pathological retinal angiogenesis in mice.
    Li YJ; Li XH; Wang LF; Kuang X; Hang ZX; Deng Y; Du JR
    Exp Eye Res; 2014 Dec; 129():119-26. PubMed ID: 25446322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruboxistaurin, a PKCbeta inhibitor, inhibits retinal neovascularization via suppression of phosphorylation of ERK1/2 and Akt.
    Nakamura S; Chikaraishi Y; Tsuruma K; Shimazawa M; Hara H
    Exp Eye Res; 2010 Jan; 90(1):137-45. PubMed ID: 19825373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
    Kim KL; Suh W
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-angiogenic effect of KH902 on retinal neovascularization.
    Wang F; Bai Y; Yu W; Han N; Huang L; Zhao M; Zhou A; Zhao M; Li X
    Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2131-9. PubMed ID: 23740520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenesis effects of endostatin in retinal neovascularization.
    Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway.
    Liu X; Zheng N; Shi YN; Yuan J; Li L
    J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.
    Seo S; Suh W
    Mol Vis; 2017; 23():823-831. PubMed ID: 29225458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF-A165b is cytoprotective and antiangiogenic in the retina.
    Magnussen AL; Rennel ES; Hua J; Bevan HS; Beazley Long N; Lehrling C; Gammons M; Floege J; Harper SJ; Agostini HT; Bates DO; Churchill AJ
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4273-81. PubMed ID: 20237249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
    Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
    Lulli M; Cammalleri M; Fornaciari I; Casini G; Dal Monte M
    Exp Eye Res; 2015 Jun; 135():67-80. PubMed ID: 25913458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
    Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
    Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrac as an anti-angiogenic agent in cancer.
    Schmohl KA; Nelson PJ; Spitzweg C
    Endocr Relat Cancer; 2019 Jun; 26(6):R287-R304. PubMed ID: 31063970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of neovascularization and expression shift of pro-/anti-angiogenic vascular endothelial growth factor isoforms after intravitreal bevacizumab injection in oxygen-induced-retinopathy mouse model.
    Shi X; Zhao M; Xie WK; Liang JH; Miao YF; DU W; Li XX
    Chin Med J (Engl); 2013 Jan; 126(2):345-52. PubMed ID: 23324288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphomannopentaose sulfate (PI-88) suppresses angiogenesis by downregulating heparanase and vascular endothelial growth factor in an oxygen-induced retinal neovascularization animal model.
    Liang XJ; Yuan L; Hu J; Yu HH; Li T; Lin SF; Tang SB
    Mol Vis; 2012; 18():1649-57. PubMed ID: 22773903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis.
    Dong X; Lei Y; Yu Z; Wang T; Liu Y; Han G; Zhang X; Li Y; Song Y; Xu H; Du M; Yin H; Wang X; Yan H
    Theranostics; 2021; 11(11):5107-5126. PubMed ID: 33859737
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifampicin inhibits the retinal neovascularization in vitro and in vivo.
    Chikaraishi Y; Matsunaga N; Shimazawa M; Hara H
    Exp Eye Res; 2008 Jan; 86(1):131-7. PubMed ID: 18031740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib Ameliorated Retinal Neovascularization by Suppressing PDGFR-α and PDGFR-β.
    Zhou L; Sun X; Huang Z; Zhou T; Zhu X; Liu Y; Wang J; Cheng B; Li M; He C; Liu X
    Cell Physiol Biochem; 2018; 48(1):263-273. PubMed ID: 30007969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.
    Schmohl KA; Mueller AM; Dohmann M; Spellerberg R; Urnauer S; Schwenk N; Ziegler SI; Bartenstein P; Nelson PJ; Spitzweg C
    Thyroid; 2019 Dec; 29(12):1843-1857. PubMed ID: 31816265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.